The Official Medtipster Blog

have your healthcare and afford it, too
Subscribe

FAQs About Blood Sugar Levels And Blood Glucose Meter Readings

October 28, 2010 By: Nadia Category: HealthCare, Medicine Advice, Medtipster, Prescription News

What should my blood sugar be??

You and your doctor will determine what your target blood sugar levels should be after some testing and properly answered questions about your diet, exercise, and any medications you are on.

For people without Diabetes, according to many doctors and experts, blood sugar levels should be:

Between 70 and 120 mg/ dL

For people with Type 2 Diabetes:

  • Fasting (not eating for a suggested period of time): up to 130 mg/dL
  • After most meals: less than 200 mg/dL

Why should I check my blood sugar?

Learning how to monitor your own blood sugar levels with a meter is a good thing to do. It helps you see how food, physical activity, and medicine affect your blood sugar levels. The readings can help you manage your Type 2 Diabetes day by day or even hour by hour. Make sure you keep a record of your results for your doctor to review.

How do I test my own blood sugar?

Consult with your doctor or pharmacist for proper technique when using the machine. Be sure you know how to test your blood sugar levels the correct way. There are many different meters out there, choose the one that makes most sense to you and recommended by either your doctor or pharmacist.

How often should I check my blood sugar levels?

Self blood sugar tests are usually done before meals, after meals, and/or at bedtime. Ask your doctor when and how often you need to check your blood sugar. Your doctor may recommend more or less than average readings.

If I test my own blood sugar levels, do I still need the A1C test?

Yes. An A1C is a 3 month average of your blood sugar levels. Therefore you cannot cheat on this test. The results of both the blood sugar tests that you do yourself and A1C tests help you and your doctor get a complete picture of your control of Type 2 Diabetes.

Visit www.medtipster.com to find a pharmacy/mini clinic in your neighborhood offering low cost Hemoglobin A1C tests!

How Two Classes of Antidiabetic Drugs Added to Metformin Impact Glycemic Control and Weight Gain

April 19, 2010 By: Nadia Category: Medicine Advice, Medtipster, Prescription News

www.Medtipster.com Source: Journal of the American Medical Association. Vol. 303 No. 14, April 14, 2010, JAMA Abstract

Metformin is the recommended initial drug therapy for patients with type 2 diabetes mellitus (DM). However, the optimal second-line drug when metformin monotherapy fails is unclear.

The study followed 11,198 individuals for an average of 32 weeks.  Researchers sought to determine the comparative efficacy, risk of weight gain, and hypoyglycemia associated with noninsulin antidiabetic drugs in patients with type 2 DM not controlled by metformin alone.  Data used included duration of patient follow-up; drug, dose, and schedule used; use of concurrent lifestyle modification; and baseline characteristics (age, sex, anthropometrics, glycated hemoglobin A1c [HbA1c], duration of DM, and metformin dose). End points collected included mean change in HbA1c, proportion of patients achieving HbA1c goal of less than 7%, change in weight, and incidence of hypoglycemia.

Study findings

  • Although use of thiazolidinediones, sulfonylureas, and glinides were associated with weight gain (range, 1.77-2.08 kg, approximatley 2 to 4 lbs.),
  • glucagon-like peptide-1 analogs, -glucosidase inhibitors, and dipeptidyl peptidase-4 inhibitors were associated with weight loss or no weight change.
  • Sulfonylureas and glinides were associated with higher rates of hypoglycemia than with placebo.

Researchers conclude that when added to maximal metformin therapy, all noninsulin antidiabetic drugs were associated with similar HbA1c reductions but differed in their associations with weight gain and risk of hypoglycemia.

Meijer To Offer Diabetes Drug At No Cost

April 13, 2010 By: Nadia Category: Free Prescriptions, Medtipster, Prescription News, Prescription Savings

Meijer Pharmacies To Dispense Metformin Immediate Release At No Cost To Prescription Holders

Type 2 Diabetes Treatment Added To The Meijer Free Antibiotics And Free Pre-Natal Vitamins Programs

Meijer announced plans to begin offering Metformin Immediate Release, the most commonly prescribed treatment for type 2 diabetes, at no cost to those with a medical prescription. Meijer’s program will include doses prescribed in 500mg, 850mg and 1000mg tablets.

According to American Diabetes Association estimates for 2007, more than 24 million Americans have diabetes, with type 2 diabetes accounting for 90-95 percent of all cases.  

Diabetes is a disease that has no cure. Currently, more than 80 million American children and adults have some form of diabetes. The Centers for Disease Control and Prevention estimates that one in three children born today will develop diabetes in their lifetime. The numbers are even worse for minorities.

Metformin Immediate Release is now believed to be the most widely prescribed anti-diabetic drug in the world. In 2008, more than 80 million prescriptions for Metformin were filled in the United States alone.

Meijer’s addition of Metformin Immediate Release to its free medication program comes just weeks after Florida-based grocer Publix led the industry by announcing it would provide free Metformin prescriptions in its pharmacy.

Find a Meijer Pharmacy carrying free Metformin at: www.medtipster.com

Early Diabetes Screening Found Cost-Effective

March 31, 2010 By: Nadia Category: Medicine Advice, Medtipster, Prescription News

Medtipster Source:  JournalWatch – www.jwatch.org

What Age Is Best to Start Screening for Diabetes Among Asymptomatic Patients?

It’s best to start screening for type 2 diabetes before middle age and to repeat screening every few years, according to a Lancet study appearing online.

Using a mathematical model, researchers first simulated a U.S. population of 325,000 nondiabetic 30-year-olds. Then they tested several screening strategies on each cohort member, measuring cost-effectiveness against a control strategy of not testing at all until diabetes symptoms or cardiovascular disease developed.

Active screening strategies ranged from starting at age 60 and then repeating every 3 years to the maximal strategy of starting at 30 with repeats every 6 months.

The best strategy — starting between 30 and 45 with repeats every 3 to 5 years — was the most cost-effective and enabled a diagnosis of diabetes some 6 years earlier than just waiting for symptoms to develop. That strategy would prevent seven myocardial infarctions and add 171 quality-adjusted life-years (QALYs) per 1000 people screened over a 50-year span.

Get Adobe Flash playerPlugin by wpburn.com wordpress themes